JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

NeoGenomics Inc

Suletud

5.82

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

5.64

Max

5.86

Põhinäitajad

By Trading Economics

Sissetulek

-19M

-45M

Müük

13M

181M

Kasumimarginaal

-24.867

Töötajad

2,200

EBITDA

-41M

-48M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+51.37% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

4. nov 2025

Turustatistika

By TradingEconomics

Turukapital

-99M

732M

Eelmine avamishind

5.82

Eelmine sulgemishind

5.82

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

11. aug 2025, 17:49 UTC

Suurimad hinnamuutused turgudel

180 Life Sciences Stock Jumps on $156 Million Notes Sale

11. aug 2025, 15:12 UTC

Suurimad hinnamuutused turgudel

SharpLink Gaming Shares Rise After Direct Offering, Ether Purchases

11. aug 2025, 13:47 UTC

Suurimad hinnamuutused turgudel

BitMine Immersion Technologies Shares Rise on Large Ethereum Holding

4. aug 2025, 16:50 UTC

Suurimad hinnamuutused turgudel

Verb Technology Shares Double After Private Placement, Intent to Buy Cryptocurrency

31. juuli 2025, 20:58 UTC

Tulu

Coinbase Global Misses on 2Q Revenue, Outlook

31. juuli 2025, 20:37 UTC

Tulu

MicroStrategy Swings to 2Q Profit on Bitcoin Gains

11. aug 2025, 12:01 UTC

Omandamised, ülevõtmised, äriostud

Empery Digital Acquired Additional 17.51 BTC for $2M Since Aug 6 >EMPD

11. aug 2025, 12:01 UTC

Omandamised, ülevõtmised, äriostud

Empery Digital Announces Exploration of Borrowing Facility to Support Opportunistic Shr Repurchases Below Net Asset Value >EMPD

11. aug 2025, 09:22 UTC

Omandamised, ülevõtmised, äriostud

MicroStrategy, Coinbase, Other Crypto Stocks Rise. What's Behind the Rally. -- Barrons.com

11. aug 2025, 08:48 UTC

Market Talk

Bitcoin Hits 4-Week High as Demand Rises -- Market Talk

8. aug 2025, 08:06 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

8. aug 2025, 08:06 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

8. aug 2025, 08:06 UTC

Market Talk

Global Equities Roundup: Market Talk

8. aug 2025, 08:06 UTC

Market Talk

Bitcoin Eases But Stays at High Level; Trump Adds Support to Crypto -- Market Talk

7. aug 2025, 07:26 UTC

Market Talk

Bitcoin Falls as Tariffs Come Into Force -- Market Talk

6. aug 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

Parataxis Holdings: Combines Bitcoin Exposure, Proprietary Growth Opportunities, Accretive Yield Generation >SBXD

6. aug 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

Parataxis Holdings: Once Proposed Transaction Is Closed, Combined Co Will Be Named Parataxis Holdings Inc. and Seek to Trade on NYSE Under the Symbol 'PRTX' >SBXD

6. aug 2025, 21:53 UTC

Omandamised, ülevõtmised, äriostud

Parataxis Holdings LLC: Entered Into a Definitive Business Combination Agreement With SilverBox Corp IV >SBXD

6. aug 2025, 14:31 UTC

Market Talk

Bitcoin Moves Can Be Unpredictable -- Market Talk

6. aug 2025, 07:14 UTC

Market Talk

Bitcoin in Period of Consolidation But Could Turn Higher -- Market Talk

5. aug 2025, 13:55 UTC

Market Talk

Bitcoin Is Being Treated as a Portfolio Diversifier -- Market Talk

5. aug 2025, 08:43 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

5. aug 2025, 08:43 UTC

Market Talk

Bitcoin Eases Amid Tariff Uncertainty -- Market Talk

4. aug 2025, 08:37 UTC

Market Talk

Bitcoin Recovers as U.S. Rate-Cut Bets Rise -- Market Talk

1. aug 2025, 22:31 UTC

Tulu

MicroStrategy Stock Drops 9%. New Equity Guidelines Could Be the Reason. -- Barrons.com

1. aug 2025, 08:22 UTC

Market Talk

Bitcoin Falls to Three-Week Low After Tariff News, Ahead of U.S. Data -- Market Talk

31. juuli 2025, 21:26 UTC

Tulu

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

31. juuli 2025, 20:43 UTC

Tulu

Riot Platforms 2Q Produced 1,426 Bitcoin, as Compared to 844 During the Same 3-Mo Period in 2024 >RIOT

31. juuli 2025, 20:43 UTC

Tulu

Riot Platforms 2Q Rev $153M >RIOT

31. juuli 2025, 20:31 UTC

Tulu

MicroStrategy Beats Earnings Estimates. The Stock Rises. -- Barrons.com

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

51.37% tõus

12 kuu keskmine prognoos

Keskmine 8.81 USD  51.37%

Kõrge 12 USD

Madal 5.5 USD

Põhineb 12 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

12 ratings

4

Osta

8

Hoia

0

Müü

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Bearish Evidence

Pikk perspektiiv

Bearish Evidence

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.